EUVIMEDEUVIMED entdecken
Crossref

Bicuspid aortopathy does not require earlier surgical intervention

Mohammad A Zafar, Jinlin Wu, Thais Faggion Vinholo, Yupeng Li, Dimitra Papanikolaou, Hesham Ellauzi, Nicolai P Ostberg, Asanish Kalyanasundaram, Paris D Kalogerakos, Sandip K Mukherjee, Bulat A Ziganshin, John A Rizzo und 1 weitere

The Journal of Thoracic and Cardiovascular Surgery · 2024

DOI: 10.1016/j.jtcvs.2023.04.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2024. Verfasst von Mohammad A Zafar und 12 weiteren Autor:innen. Beteiligte Einrichtung: Aortic Institute, Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn. Hauptthemen laut MEDLINE: Bicuspid Aortic Valve Disease, Aortic Aneurysm, Thoracic, Aortic Valve. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Guidelines for surgical correction of patients with ascending thoracic aortic aneurysm (ATAA) with a bicuspid aortic valve (BAV) have oscillated over the years. In this study, we outline the natural history of the ascending aorta in patients with BAV and trileaflet aortic valve (TAV) ATAA followed over time, to ascertain if their behavior differs and to determine if a different threshold for intervention is required. METHODS: Aortic diameters and long-term complications (ie, adverse aortic events) of 2428 patients (554 BAV and 1874 TAV) with ATAA before operative repair were reviewed. Growth rates, yearly complication rates, event-free survival, and risk of complications as a function of aortic size were calculated. Long-term follow-up and precise cause of death granularity was achieved via a comprehensive 6-pronged approach. RESULTS: Aortic growth rate in patients with BAV vs TAV ATAA was 0.20 and 0.17 cm/year, respectively (P = .009), with the rate increasing with increasing aortic size. Yearly adverse aortic events rates increased with ATAA size and were lower for patients with BAV. The relative risk of adverse aortic events exhibited an exponential increase with aortic diameter. Patients with BAV had a lower all-cause and ascending aorta-specific adverse aortic events hazard. Age-adjusted 10-year event-free survival was significantly better for patients with BAV, and BAV emerged as a protective factor against type A dissection, rupture, and ascending aortic death. CONCLUSIONS: The threshold for surgical repair of ascending aneurysm with BAV should not differ from that of TAV. Prophylactic surgery should be considered at 5.0 cm for patients with TAV (and BAV) at expert centers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bicuspid Aortic Valve DiseaseAortic Aneurysm, ThoracicAortic ValveHumansFemaleMaleMiddle AgedAgedTime FactorsRisk FactorsRetrospective StudiesRisk AssessmentProgression-Free SurvivalTime-to-TreatmentPostoperative ComplicationsHeart Valve DiseasesTreatment Outcome

Stichwörter der Autor:innen

bicuspid aortic valvebicuspid aortopathynatural historythoracic aortic aneurysmthoracic aortic dissectiontrileaflet aortic valve

Autor:innen und Institutionen

  • Aortic Institute, Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn.
  • Aortic Institute, Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn; Department of Cardiac Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academ…
  • Aortic Institute, Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn; Department of Political Sciences and Economics, Rowan University, Glassboro, NJ.
  • Aortic Institute, Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn; Department of General Surgery, Istishari Hospital, Amman, Jordan.
  • Aortic Institute, Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn; Department of Cardiovascular and Endovascular Surgery, Kazan State Medical University, Kazan, Russia.
  • Aortic Institute, Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn; Departments of Economics and Preventive Medicine, Stony Brook University, Stony Brook, NY.

Zitieren

APA

Zafar, M. A., Wu, J., Vinholo, T. F., Li, Y., Papanikolaou, D., Ellauzi, H., Ostberg, N. P., Kalyanasundaram, A., Kalogerakos, P. D., Mukherjee, S. K., Ziganshin, B. A., Rizzo, J. A., & Elefteriades, J. A. (2024). Bicuspid aortopathy does not require earlier surgical intervention. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2023.04.017

Vancouver

Zafar MA, Wu J, Vinholo TF, Li Y, Papanikolaou D, Ellauzi H, et al. Bicuspid aortopathy does not require earlier surgical intervention. The Journal of Thoracic and Cardiovascular Surgery. 2024. doi:10.1016/j.jtcvs.2023.04.017

BibTeX
@article{Zafar2024,
  author = {Zafar, Mohammad A and Wu, Jinlin and Vinholo, Thais Faggion and Li, Yupeng and Papanikolaou, Dimitra and Ellauzi, Hesham and Ostberg, Nicolai P and Kalyanasundaram, Asanish and Kalogerakos, Paris D and Mukherjee, Sandip K and Ziganshin, Bulat A and Rizzo, John A and Elefteriades, John A},
  title = {Bicuspid aortopathy does not require earlier surgical intervention},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2024},
  doi = {10.1016/j.jtcvs.2023.04.017}
}
Kostenlos starten →